Browsing by Author "MAYADAGLI, Alparslan"

Now showing items 1-3 of 3

Ascorbic-acid Treatment for Progressive Bone Metastases After Radiotherapy: A Pilot Study

MAYADAGLI, Alparslan; Kiziltan, HURİYE ŞENAY; Bayir, Ayse Gunes; TAŞPINAR, Ozgur; Meral, Ismail; Eris, ALİ HİKMET; DEMİRTAŞ, Murat; Aydin, TEOMAN (2014-01-01)

Context Researchers have reported improved survival rates for patients with cancer when 10-75 g of vitamin C (ascorbic acid, or AA) is administered intravenously. AA exhibits a cytotoxic effect upon entering a cancer cell.
Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

OZCELIK, Melike; KORKMAZ, Taner; ODABAS, Hatice; GEMICI, Cengiz; ERCELEP, Ozlem; YUKSEL, Sinemis; MERT, Aslihan Guven; SURMELI, Heves; ISIK, Deniz; AYDIN, Dincer; MAYADAGLI, Alparslan; ŞEKER, MESUT; OZDEMIR, Pınar; ALIUSTAOGLU, Mehmet; Gümüş, Mahmut (2016-07-01)
Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

Kiziltan, HURİYE ŞENAY; Bayir, Ayse Gunes; TAŞTEKİN, Didem; Coban, GANİME; Eris, ALİ HİKMET; Aydin, TEOMAN; MAYADAGLI, Alparslan (2014-01-01)

Background: Lung cancer is the most common cancer in males worldwide. The principal mode of treatment in the early stage of non-small cell lung cancer (NSCLC) is surgery. However, five-year survival is only about 15% for ...